- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00919906
My Scrivener® - Measuring Effectiveness and Dose Response in Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study builds on a large body of neurological research that uses robot-guided repetitive motion training to induce neuroplasticity and improvements in upper extremity motor skills in adults and children. This research study is looking at handwriting, a fine-motor task that is used daily.
In our study, we want to see if 3-dimensional robotic-assisted repetitive motion training can be a safe and effective intervention for school-age children with fine motor deficits arising from several different impairment origins. Our research construct is: Legible handwriting = function of (tactile feedback, visual feedback, duration, and fine-motor control).
Independent variables:
- Tactile feedback is a continuous variable of force-feedback measured in pounds of force.
- Duration is a continuous variable measured in seconds and number of repetitions.
- Visual feedback is the letter scribed on the paper.
Dependent variable:
- Legible handwriting will be measured by scoring on the Test of Handwriting Skills and the Print Tool™ evaluation.
- Fine motor deficit/control will be measured directly and objectively by quantifying the error between the desired scribing task and the actual scribing task.
The robotic device is an affordable (<$200) computer haptic (the Falcon(R)) that currently is approved by the FCC for home and office. It is *not* approved for medical use. This is an investigational, nonsignificant risk device.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97405
- Susan Palsbo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meet the following base prerequisites for writing: orientation to written language; eye-hand coordination, single handed utensil or tool manipulation (BAMF score >= 6), recognize all letters of the alphabet (unless the child has dyslexia).
- Children have illegible printing for their grade, or legible printing but a speed less than the norms for their grade and sex.
- Be able to grasp a pen.
- Be able to speak and understand English.
- Be able to follow instructions.
- Be able to devote at least 20 minutes to the assigned tasks (short breaks will be allowed).
- Be enrolled in school at grade K or above.
- A score lower than 80% on the Print Tool™ or the Cursive Tool.
Exclusion Criteria:
- Unable to pass the informed assent screener.
- Unwilling to sign or mark the informed assent documents.
- Uncontrolled spasticity.
- A BAMF score lower than 6 (includes severe paralysis of the upper extremity).
- Cerebral palsy other than hemiplegia cerebral palsy
- Severe autism or intellectual disabilities that prevent productive interactions with the investigator
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Handwriting without Tears
Standard practice
|
|
Experimental: Haptic guidance
|
Twenty 20-minute sessions of the Handwriting Without Tears(R) instructional handwriting program, with substitution of hand-over-hand or self-generated repetitive motion writing by computer guided repetitive motion.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Beery Motor Coordination Subtest
Time Frame: after 20 interventions
|
after 20 interventions
|
Print Tool and Cursive Tool
Time Frame: after 20 interventions
|
after 20 interventions
|
Deviations from desired 3-D writing path
Time Frame: after 5, 10, 15, 20 interventions
|
after 5, 10, 15, 20 interventions
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Brief Assessment of Fine Motor Skills
Time Frame: after 20 interventions
|
after 20 interventions
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Susan E Palsbo, PhD, Obslap Research LLC
Publications and helpful links
General Publications
- Bluteau J, Coquillart S, Payan Y, Gentaz E. Haptic guidance improves the visuo-manual tracking of trajectories. PLoS One. 2008 Mar 12;3(3):e1775. doi: 10.1371/journal.pone.0001775.
- O'Malley MK, Ro T, Levin HS. Assessing and inducing neuroplasticity with transcranial magnetic stimulation and robotics for motor function. Arch Phys Med Rehabil. 2006 Dec;87(12 Suppl 2):S59-66. doi: 10.1016/j.apmr.2006.08.332.
- Volman MJ, van Schendel BM, Jongmans MJ. Handwriting difficulties in primary school children: a search for underlying mechanisms. Am J Occup Ther. 2006 Jul-Aug;60(4):451-60. doi: 10.5014/ajot.60.4.451.
- Denton PL, Cope S, Moser C. The effects of sensorimotor-based intervention versus therapeutic practice on improving handwriting performance in 6- to 11-year-old children. Am J Occup Ther. 2006 Jan-Feb;60(1):16-27. doi: 10.5014/ajot.60.1.16.
- Palluel-Germain R, Bara F, Hillairet de Boisferon A, Hennion B, Gouagout P, Gentaz E. 2007. A visuo-haptic device - Telemaque - increases kindergarten children's handwriting acquisition. In proceedings of IEEE World Haptics 2007, pp72-77.
- Marr D, Dimeo SB. Outcomes associated with a summer handwriting course for elementary students. Am J Occup Ther. 2006 Jan-Feb;60(1):10-5. doi: 10.5014/ajot.60.1.10.
- Palsbo SE, Hood-Szivek P. Effect of robotic-assisted three-dimensional repetitive motion to improve hand motor function and control in children with handwriting deficits: a nonrandomized phase 2 device trial. Am J Occup Ther. 2012 Nov-Dec;66(6):682-90. doi: 10.5014/ajot.2012.004556.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Wounds and Injuries
- Neurobehavioral Manifestations
- Brain Damage, Chronic
- Craniocerebral Trauma
- Trauma, Nervous System
- Attention Deficit and Disruptive Behavior Disorders
- Neurodevelopmental Disorders
- Child Development Disorders, Pervasive
- Language Disorders
- Communication Disorders
- Learning Disabilities
- Autism Spectrum Disorder
- Cerebral Palsy
- Brain Injuries
- Brain Injuries, Traumatic
- Attention Deficit Disorder with Hyperactivity
- Dyslexia
- Asperger Syndrome
Other Study ID Numbers
- 002 (University of CT Health Center)
- #H133S070082 (Other Identifier: NIDRR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on My Scrivener(R)
-
Shenandoah UniversityCompletedHealthy ChildrenUnited States
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
The Royal Wolverhampton Hospitals NHS TrustCompletedDiabetes | Care DeliveryUnited Kingdom
-
VA Office of Research and DevelopmentCompletedDiabetes MellitusUnited States
-
Jonkoping UniversityLund University; Göteborg UniversityRecruitingMental Health Wellness 1 | Health Behavior | Satisfaction | Self Efficacy | Help-Seeking Behavior | FrustrationSweden
-
Mayo ClinicGordon and Betty Moore FoundationCompleted
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Olga Lucia SarmientoNational Cancer Institute (NCI); University of California, Los Angeles; National... and other collaboratorsCompletedBreast Cancer | Physical InactivityColombia
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting
-
Medical University of ViennaMedical University of Graz; Charite University, Berlin, Germany; Hannover Medical... and other collaboratorsCompletedSarcoma | Hematologic Diseases | Leukemia | Brain Tumor | Neurofibromatoses | NeuroblastomaAustria, Germany, Switzerland, Italy